ETOPOSIDE Sandoz 400 mg/20ml flac 20 ml
7680551650089
CH-55165
L01CB01
07.16.1.
google
Details
- Product number
- 5516502
- CPT
- -
- Packaging group
- 400mg/20ml
- Unit
- Durchstechflasche(n)
- Composition
- etoposidum 400 mg, alcohol benzylicus 400 mg, acidum citricum, ethanolum 96 per centum 5212 mg, macrogolum 300, polysorbatum 80, ad solutionem pro 20 ml corresp. ethanolum xx % V/V.
Articles (1)
Etoposid Sandoz 400 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
400mg/20ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
400.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
5212.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 55165
- Drug name
- Etoposid Sandoz, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01CB01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 20/11/2001
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ETOPOSIDE Sandoz 400 mg/20ml flac 20 ml
- Description (DE)
- ETOPOSID Sandoz 400 mg/20ml Durchstf 20 ml
- Market launch
- 20/11/2001
- Narcotic (BTM)
- No